Strand Life Sciences

Strand Life Sciences is a renowned global genomics and bioinformatics software and services leader with a primary goal to make precision medicine accessible to everyone. With our presence in India and U.S., we provide proprietary bioinformatics solutions, StrandNGS for Data Analysis, and Strandomics for the variant classification to Fortune 500 Companies. Our interdisciplinary team, consisting of highly skilled professionals from diverse backgrounds in computer science, data science, software development, bioinformatics, molecular biology, genetics, curation science, translational research, and pathology, is a true reflection of our unwavering commitment to excellence in genomics.

Pharming Group N.V.

Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com.

Cultech Ltd

Established in 1994, Cultech has become internationally recognised as both an innovator and premium quality manufacturer within the nutritional supplement industry. The powerful combination of research scientists together with formulation, process and production technologies enables Cultech to provide a fully integrative manufacturing service, involving unique formulations, innovative presentation and high quality finished products. Moreover, manufacturing flexibility and efficient customer service means that small or large scale production can be equally well accommodated. Success within the industry in the future will increasingly rely upon innovative products to allow differentiation from competitors. Our objective is to work with our customers to help ensure that the competitive edge is maintained through innovation and quality rather than compromise.

Bicycle Therapeutics

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating zelenectide pevedotin, previously BT8009, a Bicycle® Toxin Conjugate (BTC®) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC molecule targeting EphA2, a historically undruggable target; and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) targeting Nectin-4 and agonizing CD137, in company-sponsored clinical trials. Additionally, the company is developing Bicycle® Radio Conjugates (BRC™) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle® technology to develop therapies for diseases beyond oncology. Bicycle is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Cambridge, MA.

Elite Clinical Network

With 30+ years of experience, 28+ locations, and 2,000+ clinical studies conducted, Elite Clinical Network (ECN) is a trusted leader in clinical research. Our dedicated network of research sites is built on personalized service, investigator diversity, and rigorous quality processes to ensure excellence in every study. Backed by a professional corporate management team, we partner with top physicians across diverse specialties to accelerate clinical trials while maintaining the highest standards of compliance. Attention to detail drives everything we do—from site management to patient engagement. Whether you’re a medical professional looking to make an impact or a Sponsor/CRO seeking a trusted research partner, ECN offers unparalleled opportunities to drive medical advancements. Learn more at eliteclinicalnetwork.com